Advanced or Metastatic Solid Tumor Terminated Phase 1 Trials for Utomilumab (DB15113)

Also known as: Advanced / Metastatic Solid Tumor / Advanced/Metastatic Solid Tumor / Advanced and Metastatic Solid Tumor / Metastatic and Advanced Solid Tumors / Advanced and/or Metastatic Solid Tumors / Advanced or Metastatic Solid Tumors / Advanced / Metastatic Solid Tumors / Advanced/ Metastatic Solid Tumors / Advanced/Metastatic Solid Tumors

IndicationStatusPhase
DBCOND0109909 (Advanced or Metastatic Solid Tumor)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02444793A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid TumorsTreatment